Clinical Trial

A Study of YP05002 in Healthy Participants

Completed Phase 1
View on ClinicalTrials.gov →
Summary
This is a phase I, randomized, double-blind, placebo-controlled, single and multiple ascending dose study to evaluate the safety, tolerability, pharmacokinetics, efficacy, food effect of YP05002 Tablets in healthy participants
Protocol Amendment History 3 changes
critical Trial completed 2026-07-31
notable Primary completion moved earlier: 2026-04-12 -> 2026-03-13 2026-07-31
minor Completion moved earlier: 2026-06-30 -> 2026-03-13 2026-07-31
Trial Details
NCT Number NCT07089823
Lead Sponsor Yaopharma Co., Ltd.
Conditions Weight Management
Enrollment 79 participants
Start Date 2025-08-19
Primary Completion 2026-03-13 (estimated)
Study Completion 2026-03-13 (estimated)
Updated on ClinicalTrials.gov 2026-07-30